OPIOID-FORMULIERUNGEN

European patent · EP2877155 · In force

Register entry

Publication number
EP2877155
Application number
EP13744494
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Jul 26, 2013
Published
Jun 3, 2015
Granted
Oct 28, 2020
Protection ends at the latest
Jul 25, 2033
Next annual fee due
Jul 31, 2027
IPC classes
A61K 9/00 (2006.01)
A61K 47/34 (2017.01)
A61K 31/485 (2006.01)
Priority
US 201213558463 26.07.2012
US 201361806185 P 28.03.2013
PCT application
PCT/EP2013/065855 26.07.2013
PCT publication
WO2014/016428 30.01.2014
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Aug 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.07.2026 → 31.07.2027

    Published in Swissreg on 01.08.2026

  2. Jul 1, 2026

    Holder’s address changed

    Owner
    Camurus AB, Ideon Science Park, 223 70 Lund, Sweden → Camurus AB, Rydbergs torg 4, 224 84 Lund, Sweden

    Published in Swissreg on 01.07.2026

  3. Aug 1, 2025

    Next annual fee due on

    Next annual fee due on
    31.07.2025 → 31.07.2026

    Published in Swissreg on 01.08.2025

  4. Aug 1, 2024

    Change

    Published in Swissreg on 01.08.2024

  5. Aug 1, 2023

    Change

    Published in Swissreg on 01.08.2023

  6. Aug 8, 2022

    Change

    Published in Swissreg on 08.08.2022

  7. Oct 28, 2020

    Granted

    Published in Swissreg on 28.10.2020

Parties

Holder

CAMURUS AB

Camurus AB

Rydbergs torg 4, 224 84 Lund, SE

Inventor

HARWIGSSON, Ian

223 70 Lund, SE

JOHNSSON, Markus

223 70 Lund, SE

TIBERG, Fredrik

223 70 Lund, SE

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.